Exscientia | Investor Presentation Deck

Slide schematic 6/6

chart 1/1 image 1/1 list 2/2 title 2/2

Components 6

bar-vertical illustration bullet bullet action-title headline

Tools 1

list/bullet: High-value immunology target that had eluded many large biopharmas due to selectivity challenges. Balanced profile provided improvements in human whole blood potency and predicted human dose <200mg/day.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

TPP stands for Target Product Profile.